>>507079875 (OP)Some stats:
In 2019, 19.2% of U.S. adults received any mental health treatment in the past 12 months, including 15.8% who had taken prescription medication for their mental health.
During 2015–2018, 13.2% of adults aged 18 and over used antidepressant medications in the past 30 days. Use was higher among women (17.7%) than men (8.4%).
The global antidepressant drugs market accounted for $14.11 billion in 2017 and is expected to reach $15.98 billion by 2023, registering a CAGR of 2.1% during the forecast period. Major depression was most prevalent among Hispanics (10.8%), followed by African Americans (8.9%) and Whites (7.8%). The odds of depressive disorders among older Hispanics were 44% greater than among Whites (OR = 1.44; 95% CI = 1.02, 2.04), representing a significantly greater prevalence of major depression.
Iceland is the biggest consumer of antidepressants worldwide, according to recent OECD report entitled “Health at a Glance 2015.” Some 118 out of every 1,000 Icelanders now consume these drugs on a daily basis…
The National Center for Drug Abuse Statistics (NCDAS) estimates that more than 16 million American (6%) abuse prescriptions like Xanax every year. Some 4.8 million Americans use Benzodiazepines every year, with Xanax as one of the best-known brand names.
Using data analytics, researchers concluded that 12.5% of adults in the U.S. used benzodiazepines, which extrapolates to about 30.5 million persons.
Adult prevalence of antipsychotic use was 1.6%, resembling a recent U.S. outpatient sample estimate of 1.7%.
Outpatient mental health service use in the past year was highest for adults reporting two or more races (8.8 percent), white adults (7.8 percent), and American Indian or Alaska Native adults (7.7 percent), followed by black (4.7 percent), Hispanic (3.8 percent), and Asian (2.5 percent) adults.
https://wellbeingport.com/how-many-people-in-the-us-take-psychiatric-drugs/#google_vignette